BackMineralys Therapeutics Overview

Mineralys Therapeutics Current Cash

Mineralys Therapeutics's current cash is $110M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$112.78M
31.65% YoYΔ $-52.23M vs prior year quarter

Peer average

Loading

Mineralys Therapeutics Current Cash History

Loading

Mineralys Therapeutics vs. peers: Current Cash Comparison

Loading

Mineralys Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Mineralys Therapeutics (MLYS) FAQ

As of the most recent data (March 2026), MLYS shows a current cash of $110M. That compares with $170M in the prior-year period — down 31.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MLYS's current cash is now $110M (was $170M) — a 31.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Mineralys Therapeutics is outperforming or lagging.

Tracking MLYS's current cash over time shows whether Mineralys Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $110M That compares with $170M in the prior-year period — down 31.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Mineralys Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $110M) with ownership activity and broader fundamentals.